Biodesix to Participate in Two Upcoming Investor Conferences in September

On September 5, 2023 Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus in lung disease, reported Scott Hutton, Chief Executive Officer of Biodesix, will participate in two upcoming investor conferences (Press release, Biodesix, SEP 5, 2023, View Source [SID1234634878]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Morgan Stanley 21st Annual Global Healthcare Conference
Fireside Chat and 1×1 Meetings
Fireside Date: Tuesday, September 12, 2023
Fireside Time: 12:15 PM ET
Location: Sheraton Hotel, New York, NY

H.C. Wainwright 25th Annual Global Investment Conference
1×1 meetings only
Date: September 13, 2023
Location: Lotte New York Palace Hotel, New York, NY

The fireside chat at the Morgan Stanley 21st Annual Global Healthcare Conference will be webcast live and available for replay under "News & Events" in the Investors section of the Company’s website at www.biodesix.com.